SEGMENT REPORTING (Tables)

12 Months Ended

Dec. 31, 2021

SEGMENT REPORTING

Schedule of business segments

	Cure			Sera Labs			Eliminations			Consolidated
Net sales	$	651		$	6,078		$	(174	)	$	6,555
Net operating loss	$	(8,232	)	$	(6,860	)	$	-		$	(15,092	)
Assets	$	46,491		$	8,608		$	(14,175	)	$	40,574
Accounts receivable, net	$	18		$	339		$	-		$	357
Inventory, net	$	243		$	621		$	-		$	864
Interest expense	$	468		$	86		$	-		$	544
Depreciation and amortization	$	1,295		$	2,312		$	-		$	3,607

	Cure			Sera  Labs			Eliminations			Consolidated
Net sales	$	1,007		$	1,044		$	-		$	2,051
Net operating loss	$	(17,377	)	$	(1,581	)	$	-		$	(18,958	)
Assets	$	45,376		$	15,158		$	(14,175	)	$	46,359
Accounts receivable, net	$	131		$	93		$	-		$	224
Inventory, net	$	209		$	240		$	-		$	449
Interest expense	$	2,472		$	-		$	-		$	2,472
Depreciation and amortization	$	341		$	577		$	-		$	918

Schedule of disaggregation of revenue

	Year Ended December 31,
	2021			2020
CureFilm™ sales		20	%		37	%
Research & Development services		0	%		11	%
Product sales - CBD		71	%		49	%
Total		91	%		97	%